Key result
Preventive cardio-oncology requires a paradigm shift toward proactive cardiovascular risk assessment, prehabilitation, and optimization of cardiometabolic health before, during, and after cancer therapy.
May encourage pre-therapy CV optimization in cancer patients; hypothesis-generating and requires RCTs before practice change.
DOAJ is a unique and extensive index of diverse open access journals from around the world, driven by a growing community, committed to ensuring quality content is freely available online for everyone.
No takes yet. Share an insight, caveat, or question.
Sherry‐Ann Brown (2020) conducted an editorial in Cardiovascular toxicity from cancer therapies. Preventive Cardio-Oncology was evaluated. Preventive cardio-oncology requires a paradigm shift toward proactive cardiovascular risk assessment, prehabilitation, and optimization of cardiometabolic health before, during, and after cancer therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: